Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02723318
Other study ID # UCLASchickedanzFCCog
Secondary ID
Status Completed
Phase N/A
First received March 25, 2016
Last updated October 24, 2017
Start date March 2016
Est. completion date October 2017

Study information

Verified date October 2017
Source University of California, Los Angeles
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators have partnered with financial coaching organizations to establish what the investigators have termed a "Medical-Financial Partnership (MFP)" that offers financial coaching to improve financial and mental health. The investigators will evaluate the MFP's impact on cognition using the Patient Reported Outcomes Measurement Information System (PROMIS) Cognition Short form 8a.


Description:

Financial coaching is a new tool in the field of community development, but it has already demonstrated significant financial impact in a number of studies, including one randomized trial conducted by the Urban Institute. Financial coaching improves participant financial literacy, budgeting, saving for financial emergencies, and debt level. The investigators' project will help clinicians and the field of community economic development understand health and well-being through a new economic lens and assess the health-related impacts of the emerging field of financial coaching. The investigators have partnered with financial coaching organizations to establish what they have termed a "Medical-Financial Partnership (MFP)" that offers financial coaching to improve financial and mental health. The investigators will evaluate the MFP's impact on cognition using the Patient Reported Outcomes Measurement Information System (PROMIS) Cognitive Abilities Short Form.

Community-based participants will be recruited from South Los Angeles and randomized to receive either monthly financial coaching plus access to referral for social services (intervention) or access to referral for social services alone (control). Inclusion criteria include having dependents under age 18, having some form of income, and having a tax identification number (social security number or Individual tax identification number). Participants will be surveyed quarterly regarding their cognition using the PROMIS Cognitive Abilities Short Form 8-item survey.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date October 2017
Est. primary completion date October 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Participants will be included if they are caregivers/parents of one or more dependents, have some form of income, and have a tax identification number.

Exclusion Criteria:

- Inability to take part in financial coaching due to disability or primary language other than English or Spanish.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Financial Coaching
One-to-one financial coaching intervention to support savings, income, and credit while reducing debt using available tools in the community development field.
Access to Referrals to Social Services


Locations

Country Name City State
United States LIFT-LA Los Angeles California

Sponsors (1)

Lead Sponsor Collaborator
University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cognition Cognitive abilities will be assessed using the PROMIS Cognitive Abilities Survey short form 8a Up to one year (if possible)
See also
  Status Clinical Trial Phase
Completed NCT04006756 - A Study on Better Cognitive Functioning Through Braintraining on the Internet N/A
Active, not recruiting NCT02920632 - Cognitive Training in Parkinson Study N/A
Completed NCT01716975 - Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Phase 3
Completed NCT01714661 - Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Phase 3
Active, not recruiting NCT02182817 - Exposure to General Anaesthesia in Infancy and Neurocognitive Development
Completed NCT01713491 - Pre-stroke Cognitive Status and Thrombolytic Therapy N/A
Recruiting NCT01315704 - Alzheimer's Disease and Related Disorders N/A
Completed NCT01315717 - Gait and Alzheimer Interaction Tracking (GAIT) Study N/A
Completed NCT01006330 - Dysphagia in Elderly Medical Patients Phase 4
Completed NCT01818778 - The Efficacy of Using Volunteers to Implement a Cognitive Stimulation Program in Two Long-Term Care Homes N/A
Recruiting NCT01314638 - Study of Adherence and Effects of Balance Exercices (SIEL BLEU Associatio) N/A
Completed NCT01739933 - The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure Phase 3
Completed NCT02936401 - Mindfulness Based Stress Reduction for Older Adults With HIV Associated Neurocognitive Disorders N/A
Terminated NCT03095170 - Physical Exercise And Cognitive Engagement Outcomes for Mild Neurocognitive Disorder N/A
Terminated NCT03504501 - Synaptic Plasticity and Cognitive Function in RASopathies Phase 2
Recruiting NCT02290834 - Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer N/A
Completed NCT03064308 - The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major Surgery N/A
Completed NCT02265757 - Behavioral Interventions to Prevent or Delay Dementia N/A
Completed NCT01714713 - A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Phase 3
Recruiting NCT01490567 - A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia Phase 4